UTI Healthcare Fund Regular Plan Growth
3Y Annualised
23.23%
-1.08% 1D
Fund Performance
Fund Multiplier
Fund Info
Peer Comparison
Fund Managers
AMC Details
Performance
1M Returns
-2.40%
-1.08% 1D
Benchmark
N/A
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
3 years 4 months
5 years 4 months
9 years 7 months
Fund info
Fund size
₹1101.63 Cr
Min. SIP amount
₹500
Min. Lumpsum amount
₹5000
Exit load
0.01%
Period of Holding < 30 - 1%, Period of Holding = 30 days - Nil
Risk Profile
Very High Risk
This Fund's Performance Compared With Peers
Over the Period of oneMonth
1st
Baroda BNP Paribas Health and Wellness Fund Direct Growth
2nd
Baroda BNP Paribas Health and Wellness Fund Direct Payout Inc Dist cum Cap Wdrl
3rd
Baroda BNP Paribas Health and Wellness Fund Direct Reinvestment Inc Dist cum Cap Wdrl
4th
Baroda BNP Paribas Health and Wellness Fund Regular Reinvestment Inc Dist cum Cap Wdrl
5th
Baroda BNP Paribas Health and Wellness Fund Regular Growth
98th
UTI Healthcare Fund Regular Plan Growth
Fund Managers
About UTI Healthcare Fund Regular Plan Growth
UTI Healthcare Fund Regular Plan Growth is a Equity mutual fund scheme from UTI Asset Management Co Ltd. This fund has been in existence for 26 years, having been launched on 1999-06-28. UTI Healthcare Fund Regular Plan Growth has ₹1101.63 Cr worth of assets under management (AUM) as of Mon Jan 19 2026. The latest Net Asset Value (NAV) of UTI Healthcare Fund Regular Plan Growth as of Mon Jan 19 2026 is ₹275.6611. The fund has an expense ratio of 2.25%, which is medium comparable to most other Equity funds.
UTI Healthcare Fund Regular Plan Growth returns for the last 1 year are -0.39%. Since launch, it has delivered 14.53% average annual returns.
The UTI Healthcare Fund Regular Plan Growth has the majority of its money invested in Healthcare sectors.
Top 5 Holdings of UTI Healthcare Fund Regular Plan Growth.
- Sun Pharmaceuticals Industries Ltd: 9.37%
- Ajanta Pharma Ltd: 7.16%
- Lupin Ltd: 5.65%
- Glenmark Pharmaceuticals Ltd: 4.06%
- Gland Pharma Ltd: 3.60%
AMC Information
| Name | UTI Asset Management Co Ltd |
|---|---|
| Founding Date | 1999-06-28 |
| pms_care@uti.co.in | |
| Phone | +91-22-6678 6666 |
| Website | https://www.utiwms.com |
| Address | PMS Division, UTI - Tower, “Gn” Block, Bandra Kurla Complex, Mumbai- 400051 |
Tax Implications of UTI Healthcare Fund Regular Plan Growth
| Short Term Gains | 20% + applicable Surcharge + 4% Cess |
|---|---|
| Long Term Gains | 12.5% without indexation + applicable Surcharge + 4% Cess |
Similar Funds from UTI Asset Management Co Ltd
AllocationConservative Allocation
3Y CAGR
9.40%
expense ratio
1.80%
fund size
₹1703.12 Cr
EquityEquity - Other
3Y CAGR
13.49%
expense ratio
2.02%
fund size
₹2856.33 Cr
EquityLarge-Cap
3Y CAGR
13.40%
expense ratio
1.74%
fund size
₹13321.57 Cr
EquityMid-Cap
3Y CAGR
16.96%
expense ratio
1.75%
fund size
₹11956.07 Cr
EquityValue
3Y CAGR
19.42%
expense ratio
1.19%
fund size
₹10150.97 Cr
Calculate Your Returns
Estimated Returns in 3 Years (Based on past 3Y returns)
₹0
Total Amount
₹0


